Skip to content

Enhancing Cancer Prevention and Control Pathways-Native Health Initiative

Enhancing Cancer Prevention and Control Pathways-Native Health Initiative

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04259762
Enrollment
508
Registered
2020-02-06
Start date
2021-06-01
Completion date
2023-10-31
Last updated
2025-09-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cancer, Breast, Cancer, Cervix, Cancer, Colon

Keywords

breast neoplasm, colorectal neoplasm, cervical neoplasm, screening, behavioral interventions, American Indians

Brief summary

There are continued disparities in cancer incidence, mortality, and survival between American Indians (AIs) and Whites on cancers responsive to early screening (i.e., breast, colorectal, and cervical) in the US. In New Mexico (NM), AIs compared with other racial/ethnic populations are significantly less likely to adhere to recommended screening guidelines. The purpose of this trial is to develop and pilot test multilevel/multicomponent intervention strategies to enhance screening for breast, colorectal, and cervical cancers.

Detailed description

There are continued disparities in cancer incidence, mortality, and survival between American Indians (AIs) and Whites on cancers responsive to early screening (i.e., breast, colorectal, and cervical) in the US. Between 1990-2009, based on data from Contract Health Service Delivery Area Counties across the US, the mortality-to-incidence ratios for these cancers were significantly higher for American Indian/Alaska Natives compared to Whites (breast: 1.22, colorectal: 1.16, cervix: 1.36), indicating poorer survival. New Mexico (NM) AIs also experience substantial cancer disparities. Between 2010-2014, AIs compared to Whites had higher incidence (per 100,000) for cervical (7.9 vs. 6.9) and colorectal (male: 46.5 vs. 35.2; female: 29.2 vs. 28.2) cancers, and higher mortality for cervical (3.7 vs. 1.3) and colorectal (males only; 18.9 vs. 15.6) cancers. AIs were more likely to receive a late-stage (i.e., regional or distant) cancer diagnosis for all 3 screen detectable cancers. AIs have some of the lowest cancer screening rates compared with other racial/ethnic groups. In NM, AIs listed in the Indian Health Service (IHS) Albuquerque Area have substantially lower screening rates than the state's White population do. AIs had screening rates of: breast (58.5%, women ages 52-64), colorectal (41.9%, ages 50-75), and cervical (63.9%, women ages 24-64) cancers; whereas, screening rates for Whites were: breast (70.0%, ages 50-74), colorectal (69.2%, ages 50-75), and cervical (77.8%, women 21-65) The overall objective is to develop and pilot test culturally and linguistically appropriate interventions to enhance age- and risk-appropriate breast, colorectal, and cervical cancer screening in concordance with the U.S. Preventive Services Task Force recommended guidelines Aim 3 (Focus Groups, Descriptive): Qualitative documentation of perspectives on cancer control needs in the Zuni Pueblo Protocol: Aim 3 (Focus Groups, Descriptive): Qualitative documentation of perspectives on cancer control needs in the Zuni Pueblo 1. Research Design: Focus groups that gather qualitative (descriptive) perspectives and insights from a small group of participants 2. Research Setting: Zuni Pueblo 3. Participant identification and sampling: Non-probability sampling 4. Procedures: The investigators will contact interested participants for focus group sessions 5. Primary Outcome: Knowledge about, barriers and support for, and communication about breast, cervix, and colorectal cancers 6. Data Analysis: Thematic analyses of transcripts of the focus group discussions 7. Sample Size Considerations: The investigators will enroll about 8-10 participants per focus group Aim 4 (Community Survey, Descriptive): Documentation of perspectives on cancer control needs in the Zuni Pueblo Protocol: Aim 4 (Community Survey, Descriptive): Documentation of perspectives on cancer control needs in the Zuni Pueblo 1. Research Design: Cross-sectional 2. Research Setting: Zuni Pueblo 3. Participant identification and sampling: The sampling strategy for the Community Survey includes random sampling of streets, strategic convenience sampling, and snowball sampling. 4. Procedures: The investigators will implement the Community Survey among interested and eligible participants. Participants will complete surveys documenting cancer control needs for breast, cervix, or colorectal cancers. Women aged 50-75 will be surveyed on breast, cervix, and colorectal cancers; women aged 21-49 will be surveyed on cervix cancer, and men aged 50-75 will be surveyed on colorectal cancer 5. Primary Outcome: Self-reported screening behaviors for breast, colorectal, and cervix cancers 6. Data Analysis: Descriptive analysis of survey data 7. Sample Size Considerations: The investigators will enroll about 300 participants Aim 8 (INT, Pilot Test). Pilot test multilevel/multicomponent interventions on screening outcomes Protocol. Aim 8 (INT, Pilot Test): Pilot Test Effectiveness of the Multilevel/Multicomponent Intervention \[INT\] 1. Research Design: One-group, pre-INT/post-INT 2. Research Setting: Zuni Pueblo 3. Randomization: Non-randomized, convenience sampling 4. Participant Identification and Sampling: The investigators will identify and contact participants who had previously expressed interest in participating in the pilot testing of any of the 3 cancer-specific INTs 5. Interventions: Educational and behavioral INTs on cancers of the breast, colorectal, and cervix 6. Procedures: The investigators will contact interested participants and redetermine eligibility. Eligible participants will complete baseline (pre-INT) and post-INT surveys about 6-8 months after receiving the INT(s). The surveys will be administered in-person or over the phone and will last approximately 20-30 minutes 7. Implementation of the INTs: The investigators could operationalize recommended strategies that may plausibly include strategies to: To increase community access, the investigators could: (a) Identify a point-person at the health center who will triage participants to and schedule them for appropriate screening(s). (b) Remind participants to complete their screening exam(s), offer assistance in scheduling a screening appointment and a ride to the health center. These strategies would reduce administrative barriers, navigate participants, and assist with transportation and in scheduling an appointment. To increase community demand, the investigators could consider: (a) Educational materials. (b) 1-on-1 education. (c) Cognitive-behavioral group education and incentives. To increase provider delivery, the investigators could: (a) Reduce health center-specific systemic barriers by identifying a point-person to promote and facilitate screening services 8. Baseline and Post-intervention Surveys: The investigators will collect data on demographics, self-reported receipt of a cancer-specific screening exam, self-reported scheduling of an appointment to obtain a cancer-specific screening exam, or self-reported attempt to make an appointment for a cancer-specific screening exam 9. Primary Outcome: Self-reported receipt of a screening exam, or scheduling an appointment for a screening exam, or self-reported attempt to make an appointment for a screening exam. Cancer-specific screening exams include FOBT/FIT/Colonoscopy for colorectal cancer, Pap smear for cervical cancer, or mammogram for breast cancer 10. Data Analysis: The investigators will compute the count of participants who self-reported receipt of a screening exam, scheduling an appointment for a screening exam, or attempt to make an appointment for a screening exam. These analyses will be presented by age/sex strata. Men age 45-75 for colorectal cancer screening; women 45-75 for breast, cervical, and colorectal cancer screening; and women 21-49 for cervical cancer screening 11. Sample Size Considerations: The investigators will enroll a total of 120 participants

Interventions

OTHERAim 8 (INT, Pilot Test): Breast, Colorectal, and Cervical Cancer Screening Cognitive-Behavioral Interventions

Adult men and women will receive age- and gender-specific INTs. Women age 45-75 years will receive the interventions for breast, colorectal, and cervical cancers screening. Men age 45-75 years will receive the intervention for colorectal cancer screening. Women age 21-49 years will receive the intervention for cervical cancer screening. The cognitive-behavioral INTs on age-gender specific cancers will range from 1-2 hours. The study team will utilize a digital flipchart that will cover each cancer's specific risk/protective factors, incidence, mortality, screening methods, and resources. The study team member delivering the INTs will function as a facilitator linking information with practical skills.

Sponsors

University of New Mexico
CollaboratorOTHER
National Institute of General Medical Sciences (NIGMS)
CollaboratorNIH
New Mexico Cancer Research Alliance
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
SCREENING
Masking
NONE

Intervention model description

Enrollment numbers for Aims 3 and 4 are 96 and 281, respectively. The enrollment number n=131 is for Aim 8, INT, Pilot Test only.

Eligibility

Sex/Gender
ALL
Age
21 Years to 75 Years
Healthy volunteers
Yes

Inclusion criteria

Breast Cancer Screening Intervention * Women age 45-75 * Average risk for breast cancer * Never had a mammogram OR not had a mammogram within the past 2 years * Residing in the Zuni Pueblo

Exclusion criteria

Breast Cancer Screening Intervention. Meeting at least one of the following criteria: * Women with breast implants, pregnant, or breast feeding * History of breast cancer * Have new breast complaints such as lump or nipple discharge Inclusion Criteria: Colorectal Cancer Screening Intervention * Men and women aged 45-75 * Average risk for colorectal cancer * Never had a fecal occult blood test (FOBT), or fecal immunochemical test (FIT) or a colonoscopy OR not had a FOBT or FIT in the past year, OR no colonoscopy in the past 10 years * Residing in the Zuni Pueblo

Design outcomes

Primary

MeasureTime frameDescription
Aim 3, Focus Groups, Descriptive: Knowledge, Barriers and Support, and Communication About Breast, Cervix, and Colorectal Cancers12 monthsThe focus group discussion documents the participants' knowledge about, barriers and support for, and communications about cancer and cancer prevention. Focus group methodology is primarily a qualitative research method and directly quantifying themes is not the typical approach. In this research, only qualitative data were collected with no quantification other than of the number of participants that endorsed a particular theme
Aim 4, Community Survey, Descriptive: Cancer Control Needs7 monthsAge/gender specific self-reported screening behaviors for breast, colorectum, and cervical cancers
Aim 8, INT, Pilot Test: Age/Gender-specific Breast, Colorectal, and Cervical Cancer Screening8 monthsSelf-reported receipt of a screening exam, or scheduling an appointment for a screening exam, or self-reported attempt to make an appointment for a screening exam. Cancer-specific screening exams included FOBT/FIT/Colonoscopy for colorectal cancer for men and women 45-75 years, Pap smear for cervical cancer for women 21-75 years, or mammogram for breast cancer for women 45-75 years

Countries

United States

Participant flow

Recruitment details

For Aim 3 (Focus Groups, Descriptive): Enrollment n=96, For Aim 4 (Community Survey, Descriptive): Enrollment n=281 For Aim 8 (INT, Pilot Test), recruited 131 participants who had expressed interest to participate in the pilot test of the 3 cancer-specific INTs. The recruitment, followed by the baseline (pre-INT) survey, the 3 cancer-specific INTs, and the post-INT, were conducted between December 2022 and April 2023. Convenience sampling methods were used to recruit the participants

Pre-assignment details

For Aim 3: Recruitment n=96, For Aim 4: Recruitment n=281, For Aim 8 (INT, Pilot Test), out of the 131 participants enrolled, 117 participants completed all Aim 8 study activities (pre- and post-INT surveys, educational and behavioral INT(s)). Preliminary data on these 117 participants are reported herein. The Zuni Pueblo's Tribal leadership has approved the findings for their wider dissemination. Aims 1, 2, 5, 6, and 7 were descriptive in nature, with no data collection.

Participants by arm

ArmCount
Aim 3, Focus Groups, Descriptive: Cancer Control Needs
Trained focus group facilitators conducted the focus groups. Each session lasted approximately two hours. The facilitators used a semi-structured focus group guide to explore needs around cancer prevention and control, including knowledge, barriers and support, and communications. Conducted 11 focus groups with Community members (Community, N=85) and 1 focus group with providers (Provider, N=11)
96
Aim 4, Community Survey, Descriptive: Cancer Control Needs
The study team conducted surveyed interested participants on their cancer screening practices. The surveys were age/gender specific. Women ages 50-75 were surveyed on breast, cervical, and colorectal cancers. Women aged 21-49 were surveyed on cervical cancer. Men aged 50-75 were surveyed on colorectal cancer
281
Aim 8, INT, Pilot Test: Breast, Colorectal, and Cervical Cancer Screening
For Aim 8 (INT Pilot Test), the investigators will train Community Health Representatives (CHRs) in interactive group discussions techniques. CHRs will administer 1 session/week, lasting approximately 2 hours, and conducted among 12 men or women ages 21-75 per cluster. The CHRs will distribute the cancer-specific (i.e., breast, colorectal, and cervical) small media during the first session and refer to it during the course of the 4 sessions. During the sessions, the CHRs will function as a facilitator linking information with practical skills. At the end of the 4-week INT, participants will receive a voucher to present to a designated point-person at the health center who would schedule the screening for the age- and gender-specific cancers. Breast, Colorectal, and Cervical Cancer Screening Interventions (Aim 8, INT, Pilot Test): Women age 50-75 years will receive the interventions for breast, colorectal, and cervical cancers screening. Men age 50-75 years will receive the intervention for colorectal cancer screening. Women age 21-49 years will receive the intervention for cervical cancer screening. The 4-week interventions, delivered once a week, will consist of educational sessions that discuss cancer-specific information (i.e., breast, colorectal, and cervical cancer): breast (colorectal, cervical) cancer myths and facts, risk factors and symptoms, screening, and review/action plan. The educational sessions will be complemented by cancer-specific small media (brochure).
117
Total494

Baseline characteristics

CharacteristicAim 3, Focus Groups, Descriptive: Cancer Control NeedsAim 4, Community Survey, Descriptive: Cancer Control NeedsAim 8, INT, Pilot Test: Breast, Colorectal, and Cervical Cancer ScreeningTotal
Age, Categorical
<=18 years
0 Participants0 Participants0 Participants0 Participants
Age, Categorical
>=65 years
11 Participants55 Participants15 Participants81 Participants
Age, Categorical
Between 18 and 65 years
85 Participants226 Participants102 Participants413 Participants
Race (NIH/OMB)
American Indian or Alaska Native
83 Participants281 Participants117 Participants481 Participants
Race (NIH/OMB)
Asian
0 Participants0 Participants0 Participants0 Participants
Race (NIH/OMB)
Black or African American
0 Participants0 Participants0 Participants0 Participants
Race (NIH/OMB)
More than one race
0 Participants0 Participants0 Participants0 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants0 Participants0 Participants0 Participants
Race (NIH/OMB)
Unknown or Not Reported
3 Participants0 Participants0 Participants3 Participants
Race (NIH/OMB)
White
10 Participants0 Participants0 Participants10 Participants
Sex: Female, Male
Female
61 Participants171 Participants72 Participants304 Participants
Sex: Female, Male
Male
35 Participants110 Participants45 Participants190 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
EG002
affected / at risk
deaths
Total, all-cause mortality
0 / 960 / 2810 / 117
other
Total, other adverse events
0 / 960 / 2810 / 117
serious
Total, serious adverse events
0 / 960 / 2810 / 117

Outcome results

Primary

Aim 3, Focus Groups, Descriptive: Knowledge, Barriers and Support, and Communication About Breast, Cervix, and Colorectal Cancers

The focus group discussion documents the participants' knowledge about, barriers and support for, and communications about cancer and cancer prevention. Focus group methodology is primarily a qualitative research method and directly quantifying themes is not the typical approach. In this research, only qualitative data were collected with no quantification other than of the number of participants that endorsed a particular theme

Time frame: 12 months

Population: The number analyzed in each row is based on the total number of participants (Community N=85 in 11 focus groups; Providers N=11 in one focus group) who took part in the focus group sessions

ArmMeasureGroupValue (COUNT_OF_PARTICIPANTS)
Aim 3, Focus Groups, Descriptive Cancer Control NeedsAim 3, Focus Groups, Descriptive: Knowledge, Barriers and Support, and Communication About Breast, Cervix, and Colorectal CancersKnowledge (Community): Variable knowledge and awareness regarding cancer and screening85 Participants
Aim 3, Focus Groups, Descriptive Cancer Control NeedsAim 3, Focus Groups, Descriptive: Knowledge, Barriers and Support, and Communication About Breast, Cervix, and Colorectal CancersKnowledge (Community): Need information about cancers, screening tests, and prevention85 Participants
Aim 3, Focus Groups, Descriptive Cancer Control NeedsAim 3, Focus Groups, Descriptive: Knowledge, Barriers and Support, and Communication About Breast, Cervix, and Colorectal CancersKnowledge (Community): Range of views regarding causality85 Participants
Aim 3, Focus Groups, Descriptive Cancer Control NeedsAim 3, Focus Groups, Descriptive: Knowledge, Barriers and Support, and Communication About Breast, Cervix, and Colorectal CancersKnowledge (Community): Receptivity to preventive strategies85 Participants
Aim 3, Focus Groups, Descriptive Cancer Control NeedsAim 3, Focus Groups, Descriptive: Knowledge, Barriers and Support, and Communication About Breast, Cervix, and Colorectal CancersKnowledge (Provider): Low screening due to individual-/system-level barriers11 Participants
Aim 3, Focus Groups, Descriptive Cancer Control NeedsAim 3, Focus Groups, Descriptive: Knowledge, Barriers and Support, and Communication About Breast, Cervix, and Colorectal CancersBarriers/Support (Community): Systemic barriers85 Participants
Aim 3, Focus Groups, Descriptive Cancer Control NeedsAim 3, Focus Groups, Descriptive: Knowledge, Barriers and Support, and Communication About Breast, Cervix, and Colorectal CancersBarriers/Support (Community): Confidentiality concerns85 Participants
Aim 3, Focus Groups, Descriptive Cancer Control NeedsAim 3, Focus Groups, Descriptive: Knowledge, Barriers and Support, and Communication About Breast, Cervix, and Colorectal CancersBarriers/Support (Community): Benefits of supportive elements to promote better health85 Participants
Aim 3, Focus Groups, Descriptive Cancer Control NeedsAim 3, Focus Groups, Descriptive: Knowledge, Barriers and Support, and Communication About Breast, Cervix, and Colorectal CancersBarriers/Support (Provider): Fear/denial, fatalism, and procrastination11 Participants
Aim 3, Focus Groups, Descriptive Cancer Control NeedsAim 3, Focus Groups, Descriptive: Knowledge, Barriers and Support, and Communication About Breast, Cervix, and Colorectal CancersBarriers/Support (Provider): Social determinants of health11 Participants
Aim 3, Focus Groups, Descriptive Cancer Control NeedsAim 3, Focus Groups, Descriptive: Knowledge, Barriers and Support, and Communication About Breast, Cervix, and Colorectal CancersBarriers/Support (Provider): Competing priorities and social conditions11 Participants
Aim 3, Focus Groups, Descriptive Cancer Control NeedsAim 3, Focus Groups, Descriptive: Knowledge, Barriers and Support, and Communication About Breast, Cervix, and Colorectal CancersBarriers/Support (Provider): Systems-level barriers11 Participants
Aim 3, Focus Groups, Descriptive Cancer Control NeedsAim 3, Focus Groups, Descriptive: Knowledge, Barriers and Support, and Communication About Breast, Cervix, and Colorectal CancersCommunication (Community): Discuss cancer screening with family85 Participants
Aim 3, Focus Groups, Descriptive Cancer Control NeedsAim 3, Focus Groups, Descriptive: Knowledge, Barriers and Support, and Communication About Breast, Cervix, and Colorectal CancersCommunication (Community): Confidence, trust, gender concordance eases communications85 Participants
Aim 3, Focus Groups, Descriptive Cancer Control NeedsAim 3, Focus Groups, Descriptive: Knowledge, Barriers and Support, and Communication About Breast, Cervix, and Colorectal CancersCommunication (Community): Cultural traditions, gender norms, privacy concern preclude communication85 Participants
Aim 3, Focus Groups, Descriptive Cancer Control NeedsAim 3, Focus Groups, Descriptive: Knowledge, Barriers and Support, and Communication About Breast, Cervix, and Colorectal CancersCommunication (Community): Systems-level factors preclude healthcare discussions85 Participants
Aim 3, Focus Groups, Descriptive Cancer Control NeedsAim 3, Focus Groups, Descriptive: Knowledge, Barriers and Support, and Communication About Breast, Cervix, and Colorectal CancersCommunications (Provider): Prioritize communication about cancer screening11 Participants
Aim 3, Focus Groups, Descriptive Cancer Control NeedsAim 3, Focus Groups, Descriptive: Knowledge, Barriers and Support, and Communication About Breast, Cervix, and Colorectal CancersCommunications (Provider): Aware about screening but not going through it11 Participants
Aim 3, Focus Groups, Descriptive Cancer Control NeedsAim 3, Focus Groups, Descriptive: Knowledge, Barriers and Support, and Communication About Breast, Cervix, and Colorectal CancersCommunications (Provider): Utilize culturally tailored counseling strategies11 Participants
Aim 3, Focus Groups, Descriptive Cancer Control NeedsAim 3, Focus Groups, Descriptive: Knowledge, Barriers and Support, and Communication About Breast, Cervix, and Colorectal CancersCommunications (Provider): Use humor11 Participants
Comparison: All focus groups were summarized together and, therefore, the denominators (N=85 \[Community\], N=11 \[Provider\]) for each theme are the same. Further, the focus groups only made qualitative (and no quantitative) assessments/endoresement of themes. No formal comparisons among groups were made.
Primary

Aim 4, Community Survey, Descriptive: Cancer Control Needs

Age/gender specific self-reported screening behaviors for breast, colorectum, and cervical cancers

Time frame: 7 months

Population: The Number Analyzed in each row reflects the number of participants assessed, while the values reported in the data fields reflect the number of participants who Ever Had the respective screening examinations

ArmMeasureGroupValue (COUNT_OF_PARTICIPANTS)
Aim 3, Focus Groups, Descriptive Cancer Control NeedsAim 4, Community Survey, Descriptive: Cancer Control NeedsEver Had A Mammogram To Screen For Breast Cancer, Women 50-75 years95 Participants
Aim 3, Focus Groups, Descriptive Cancer Control NeedsAim 4, Community Survey, Descriptive: Cancer Control NeedsEver Completed an FOBT or Colonoscopy To Screen For Colorectal Cancer, Men and Women 50-75 years92 Participants
Aim 3, Focus Groups, Descriptive Cancer Control NeedsAim 4, Community Survey, Descriptive: Cancer Control NeedsEver Had a Pap Test and/or HPV Test To Screen For Cervical Cancer, Women 21-75 years129 Participants
Primary

Aim 8, INT, Pilot Test: Age/Gender-specific Breast, Colorectal, and Cervical Cancer Screening

Self-reported receipt of a screening exam, or scheduling an appointment for a screening exam, or self-reported attempt to make an appointment for a screening exam. Cancer-specific screening exams included FOBT/FIT/Colonoscopy for colorectal cancer for men and women 45-75 years, Pap smear for cervical cancer for women 21-75 years, or mammogram for breast cancer for women 45-75 years

Time frame: 8 months

Population: The number analyzed in each row is based on age/gender strata and the respective cancer screening test. Men and women age 45-75 were eligible for colorectal cancer screening test. Women age 45-75 were eligible for breast cancer screening test, women 21-75 were eligible for cervical cancer screening test.

ArmMeasureGroupValue (COUNT_OF_PARTICIPANTS)
Aim 3, Focus Groups, Descriptive Cancer Control NeedsAim 8, INT, Pilot Test: Age/Gender-specific Breast, Colorectal, and Cervical Cancer ScreeningStool Test, Men, 45-75 years (Aim 8, INT, Pilot Test)20 Participants
Aim 3, Focus Groups, Descriptive Cancer Control NeedsAim 8, INT, Pilot Test: Age/Gender-specific Breast, Colorectal, and Cervical Cancer ScreeningStool Test, Women, 45-75 years (Aim 8, INT, Pilot Test)28 Participants
Aim 3, Focus Groups, Descriptive Cancer Control NeedsAim 8, INT, Pilot Test: Age/Gender-specific Breast, Colorectal, and Cervical Cancer ScreeningColonoscopy, Men, 45-75 years (Aim 8, INT, Pilot Test)11 Participants
Aim 3, Focus Groups, Descriptive Cancer Control NeedsAim 8, INT, Pilot Test: Age/Gender-specific Breast, Colorectal, and Cervical Cancer ScreeningColonoscopy, Women, 45-75 years (Aim 8, INT, Pilot Test)15 Participants
Aim 3, Focus Groups, Descriptive Cancer Control NeedsAim 8, INT, Pilot Test: Age/Gender-specific Breast, Colorectal, and Cervical Cancer ScreeningMammogram, Women, 45-75 years (Aim 8, INT, Pilot Test)26 Participants
Aim 3, Focus Groups, Descriptive Cancer Control NeedsAim 8, INT, Pilot Test: Age/Gender-specific Breast, Colorectal, and Cervical Cancer ScreeningPap Smear, Women, 45-75 years (Aim 8, INT, Pilot Test)23 Participants
Aim 3, Focus Groups, Descriptive Cancer Control NeedsAim 8, INT, Pilot Test: Age/Gender-specific Breast, Colorectal, and Cervical Cancer ScreeningPap Smear, Women, 21-44 years (Aim 8, INT, Pilot Test)21 Participants
95% CI: [0.303, 0.831]

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026